Objectives: Adverse drug reactions are common, serious, difficult to predict, and may be influenced by genetics, prompting the increasing popularity of pharmacogenomic studies. Many pharmacogenomic studies are conducted in nonexperimental settings, yet little is known about the influence of confounding by contraindication. We, therefore, compared the two designs [the overall population (OPD) and the treated-only (TOD) design] by simulating a pharmacogenomic study of the ECG QT interval (QT).
Methods: Simulations were informed by data from the Atherosclerosis Risk in Communities Study and a literature review examining QT, QT-prolonging drug use, and modification by single nucleotide polymorphisms (SNP). Drug treatment was assigned on the basis of age, sex, and QTlong, representing confounding by contraindication. QT was simulated as a function of drug treatment, one SNP, the drug-SNP interaction, and clinical covariates.
Results: Failure to adjust for confounding by contraindication produced a varying degree of bias in the OPD, whereas the TOD was biased by the SNP main effect. For example, in the OPD, the false-positive proportion for the drug-SNP interaction was 5% across the range of SNP main effects (0-10 ms), but increased to 19% without adjusting for confounding by contraindication. In the TOD, the false-positive proportion increased to 89% with SNP main effects greater than 4 ms, although bias was reduced by 39% with adjustment for covariates affected by the SNP.
Conclusion: The potential for bias from confounding by contraindication (OPD) should be weighed against bias from SNP main effects (TOD) when selecting the study design that best suits the given context.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946643 | PMC |
http://dx.doi.org/10.1097/FPC.0000000000000027 | DOI Listing |
Reprod Biomed Online
August 2024
Division of Reproductive Endocrinology and Infertility, Massachusetts General Hospital Fertility Center, Department of Obstetrics, Gynecology and Reproductive Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Research Question: Are there differences in the rates of hypertensive disorders of pregnancy among IVF patients who underwent induction of labour at 39 weeks compared with those who were managed expectantly?
Design: This was a retrospective cohort study of 1176 low-risk singleton pregnancies conceived via IVF with no contraindications to vaginal delivery. Two groups were constructed: elective induction of labour from 39 weeks 0 days to 39 weeks 6 days (n = 234); and expectant management (n = 942). The main outcome measure was the incidence of hypertensive disorders of pregnancy.
Pregnancy Hypertens
December 2024
Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
Pediatr Transplant
December 2024
Division of Abdominal Organ Transplantation and Hepatobiliary Surgery, Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain.
Background: Pediatric hepatocellular carcinoma (HCC) presents significant challenges due to its aggressive nature, with survival depending on complete resection. We aimed to assess outcomes between liver resection (LR) and liver transplantation (LT).
Methods: A total of 25 patients were retrieved, four of whom were classified as palliative at diagnosis.
J Gynecol Obstet Hum Reprod
October 2024
Université de Paris, Centre for Research in Epidemiology and Statistics (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team - INSERM U1153, Paris, France; Port-Royal Maternity Unit, Cochin Hospital, APHP, Paris, France.
J Trauma Acute Care Surg
September 2024
From the Division of Acute Care Surgery (R.T.B., M.F., B.M.D.), Vanderbilt University Medical Center, Nashville, Tennessee; Division of General Surgery (M.W.W.), University of Utah School of Medicine, Salt Lake City, Utah; Department of Anesthesiology (N.S., B.A., A.N.W.), Vanderbilt University Medical Center, Nashville, Tennessee; Department of Pharmacy Practice (S.E.H.), Lipscomb University College of Pharmacy and Health Sciences, Nashville, Tennessee; Department of Biomedical Informatics (E.W., S.D.N.), Vanderbilt University Medical Center, Nashville, Tennessee; Paradigm Health (M.D.M.), PLLC, Franklin, Tennessee; Vanderbilt University School of Medicine (D.R.); and Department of Biostatistics (F.Y., R.I.), and Department of Medicine (F.Y.), Vanderbilt University Medical Center, Nashville, Tennessee.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!